Evidence map›Paper›PMID 40191816›Full record

ArticleIUCrData2025

2-Oxo-2

Hypolite Bazié, Eric Ziki, Sorgho Brahima, Veroarisinima Ratsimbazafy, Patrick Roge, Emmanuel Wenger, Abdoulaye Djandé, Claude Lecomte

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in IUCrData, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. 2-Oxo-2IUCrData · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hypolite BaziéLaboratory of Molecular Chemistry and Materials (LC2M), University Joseph KI-ZERBO, 03 BP 7021 Ouagadougou 03, Burkina Faso.
Eric ZikiLaboratory of Matter Environmental and Solar Energy Sciences Research Team: Crystallography and Molecular Physics University Félix Houphouët-Boigny 08 BP 582 Abidjan 22 Côte d'Ivoire.ORCID https://orcid.org/0009-0002-0130-4463
Sorgho BrahimaLaboratory of Molecular Chemistry and Materials (LC2M), University Joseph KI-ZERBO, 03 BP 7021 Ouagadougou 03, Burkina Faso.
Veroarisinima RatsimbazafyLaboratory of Solid State Physics and Experimental Physics, University of Antananarivo, BP 566, Antananarivo 101, Madagascar.
Patrick RogeLaboratory of Solid State Physics and Experimental Physics, University of Antananarivo, BP 566, Antananarivo 101, Madagascar.
Emmanuel WengerCRM2, CNRS-Université de Lorraine, Vandoeuvre-lès-Nancy CEDEX BP 70239, France.ORCID https://orcid.org/0000-0001-7807-5182
Abdoulaye DjandéLaboratory of Molecular Chemistry and Materials (LC2M), University Joseph KI-ZERBO, 03 BP 7021 Ouagadougou 03, Burkina Faso.
Claude LecomteCRM2, CNRS-Université de Lorraine, Vandoeuvre-lès-Nancy CEDEX BP 70239, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the title compound, C

Indexed as

coumarincrystal structureHirshfeld surfacehydrogen bond

Identifiers

PMID40191816
PMCPMC11969393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.